BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22921465)

  • 1. Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer.
    Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF
    J Crohns Colitis; 2013 Jun; 7(5):403-11. PubMed ID: 22921465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
    Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease.
    Miseljic S; Galandiuk S; Myers SD; Wittliff JL
    J Clin Lab Anal; 1995; 9(6):413-7. PubMed ID: 8587011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
    Thor A; Itzkowitz SH; Schlom J; Kim YS; Hanauer S
    Int J Cancer; 1989 May; 43(5):810-5. PubMed ID: 2654025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum.
    Krause P; Bobisch NS; Thelen P; Koehler K; Koenig S; Becker H; Leister I
    Int J Colorectal Dis; 2011 Jan; 26(1):37-43. PubMed ID: 20931209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro.
    Shetty S; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L148-56. PubMed ID: 10645902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer.
    Levine DS; Rabinovitch PS; Haggitt RC; Blount PL; Dean PJ; Rubin CE; Reid BJ
    Gastroenterology; 1991 Nov; 101(5):1198-210. PubMed ID: 1936790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.
    Cartwright CA; Coad CA; Egbert BM
    J Clin Invest; 1994 Feb; 93(2):509-15. PubMed ID: 7509341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
    Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
    J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant potential of chronic ulcerative colitis. Preliminary report.
    Nugent FW; Haggit RC; Colcher H; Kutteruf GC
    Gastroenterology; 1979 Jan; 76(1):1-5. PubMed ID: 758130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell adhesion induces the plasminogen activator inhibitor-1 gene expression through phosphatidylinositol 3-kinase/Akt activation in anchorage dependent cells.
    Chang H; Shyu KG; Lin S; Wang BW; Liu YC; Lee CC
    Cell Commun Adhes; 2002; 9(5-6):239-47. PubMed ID: 12745435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients.
    Halamkova J; Kiss I; Pavlovsky Z; Tomasek J; Jarkovsky J; Cech Z; Tucek S; Hanakova L; Moulis M; Zavrelova J; Man M; Benda P; Robek O; Kala Z; Penka M
    Neoplasma; 2011; 58(5):377-85. PubMed ID: 21744990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
    Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
    Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells.
    Paugh BS; Paugh SW; Bryan L; Kapitonov D; Wilczynska KM; Gopalan SM; Rokita H; Milstien S; Spiegel S; Kordula T
    FASEB J; 2008 Feb; 22(2):455-65. PubMed ID: 17855624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
    Ullman T; Croog V; Harpaz N; Sachar D; Itzkowitz S
    Gastroenterology; 2003 Nov; 125(5):1311-9. PubMed ID: 14598247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.